TD Asset Management
INFI

TD Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

TD Asset Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,200
Closed -$189K – 1415
2014
Q4 		$189K Sell
11,200
-4,400
-28% -$64.1K ﹤0.01% 1341
2014
Q3 		$209K Buy
+15,600
New +$186K ﹤0.01% 1240
2013
Q4 		– Sell
-51,825
Closed -$904K – 1315
2013
Q3 		$904K Buy
51,825
+5,100
+11% +$97.7K ﹤0.01% 881
2013
Q2 		$759K Buy
+46,725
New +$1.45M ﹤0.01% 872

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TD Asset Management's INFI Position: Q1 2015 in Review

TD Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2015, closing a stake of 11,200 shares — an estimated $189K sold.

TD Asset Management first reported a position in INFI in Q2 2013 and held it in 4 quarters. The position peaked at $904K in Q3 2013. 141 funds tracked by Wall St. Rank hold INFI as of Q1 2015.

  • TD Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • TD Asset Management sold 11,200 Infinity Pharmaceuticals, Inc. shares in Q1 2015, an estimated $189K.
  • TD Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
  • TD Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $904K in Q3 2013.
  • 141 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2015.

Based on TD Asset Management's 13F filing for Q1 2015, filed 28 Apr 2015.